The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia.

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision."

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was in keeping with the objectives of the project “PRIN 2020LM8WNW (E69I20200120006)”, Department of Clinical and Experimental Medicine, University of Catania. Genetic analysis was carried out within the Lipigen study, an initiative of the SISA Foundation supported by an unconditional research grant from Sanofi; the genetic assessment was performed in collaboration with GenInCode, Barcelona, Spain."